T1	Participants 207 270	231 patients with chronic reversible obstructive airway disease
T2	Participants 996 1096	patients who expressed a preference for one of the delivery systems, half preferred using the powder
T3	Participants 761 855	physicians' assessments of patients' clinical response, or patients' subjective symptom scores
